Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia
about
Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigensA human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemiaA novel approach to identify antigens recognized by CD4 T cells using complement-opsonized bacteria expressing a cDNA library.Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modality.Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy.Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection.Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia.Allogeneic immune replacement as cancer immunotherapy.Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation.Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution.STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacity.Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.Acute lymphoblastic leukemia cells treated with CpG oligodeoxynucleotides, IL-4 and CD40 ligand facilitate enhanced anti-leukemic CTL responses.Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model.Antigens shared by malignant plasma cells and normal B cells may be involved in graft versus myeloma.Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia.TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cells.The biological therapy of acute and chronic leukemia.Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia.Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study.Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia.In vitro and in vivo characterization of graft-versus-tumor responses in melanoma patients after allogeneic peripheral blood stem cell transplantation.HLA class II restricted T-cell receptor gene transfer generates CD4+ T cells with helper activity as well as cytotoxic capacity.Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells.In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy.Intracellular cytokine analysis of interferon-gamma in T cells of patients with chronic myeloid leukemia.Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantation
P2860
Q24673417-28D49262-74BE-4F81-AD66-9FAFBC7B002FQ30274634-02AA9FF5-7BF0-4D91-8E94-865174170FD6Q30679410-B13AA96B-2545-4D4B-BEDF-D7F6A915C057Q33208694-41073D0B-02F4-4589-80C2-A29962A838D3Q33788194-5AB8194D-5F31-4868-81A7-2CF95DC288CCQ33931811-1F41AAA6-F528-44C4-AB3F-A09A0B409FD1Q34089112-13C53809-1F86-4156-83CE-65B4C3EACDAAQ34207168-B218646D-6BD4-46AC-9542-36C9D5C5DA37Q34255174-32F3F272-51E8-46AC-9684-1FB6E669CA4EQ35217408-8B087093-2193-468A-BE8B-CE79572940AAQ35547257-AA0BD8CB-69BE-42FF-BD0F-448A0BE5B169Q35752628-BB8887BA-175A-4028-A04E-CEB7A22E91D1Q36287359-811C3F05-8E0D-4904-8799-A51EB0C53640Q37131658-B3C2543A-DBB3-4784-951F-F6CFA5B2EC85Q37496786-91CD5ECF-47F2-4A6A-82FA-4065358A5167Q38905932-E5981E45-6F13-4204-9232-16D80149A716Q39551385-6690B054-8C83-4C6E-BDAE-F71E431E7954Q40115182-BA8FFE13-BD51-47F1-BD9C-1A689BC05FE8Q40673497-DA2FB355-FE75-465A-90AA-0B22116DF486Q40764861-E7115342-3212-4CB8-AE00-D452FE8BC105Q40794623-D3B3405C-2B26-4700-86AA-2F9270C295D8Q41552414-9E1D244A-992E-4FAD-A917-F47027B49F52Q41561760-0DEB990D-C2A2-487C-8F71-C6D13441EA74Q42072632-655E2322-D624-44C8-9437-461DBFBA4715Q43830905-8B61759E-3264-4BC7-8F71-DA764E5E5272Q44124088-4B50B870-805D-4505-83FF-9E79E15EDFCCQ45885235-CDDD5D80-D7ED-4085-B082-E5D8A71DADEAQ51028658-D116E34C-DFF5-4AFF-ADF3-9E1CF565888BQ52006038-952F7619-E910-4078-A561-61E938350BE6Q54787150-095F5B7C-ABC5-4A70-B711-5252D9CDE81DQ59194369-B0907581-CA51-419F-8F13-DCF350ED1D8F
P2860
Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Generation of leukemia-reactiv ...... nor of a patient with leukemia
@ast
Generation of leukemia-reactiv ...... nor of a patient with leukemia
@en
type
label
Generation of leukemia-reactiv ...... nor of a patient with leukemia
@ast
Generation of leukemia-reactiv ...... nor of a patient with leukemia
@en
prefLabel
Generation of leukemia-reactiv ...... nor of a patient with leukemia
@ast
Generation of leukemia-reactiv ...... nor of a patient with leukemia
@en
P2093
P2860
P921
P356
P1476
Generation of leukemia-reactiv ...... nor of a patient with leukemia
@en
P2093
Falkenburg JH
Willemze R
van Luxemburg-Heijs SA
P2860
P304
P356
10.1084/JEM.176.5.1283
P407
P577
1992-11-01T00:00:00Z